Nigel J Bundred Selected Research

Nigel J Bundred Research Topics

Disease

29	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2002
17	Neoplasms (Cancer) 05/2021 - 01/2002
15	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2021 - 01/2002
4	Neoplasm Metastasis (Metastasis) 08/2020 - 09/2006
1	Lung Neoplasms (Lung Cancer) 08/2020
1	Stroke (Strokes) 08/2020
1	Atrial Fibrillation 08/2020
1	Thrombophilia 01/2020
1	Lymphadenopathy 11/2014
1	Breast Ductal Carcinoma 01/2013
1	Pain (Aches) 03/2008
1	Mastitis 02/2008
1	Inflammatory Breast Neoplasms 02/2008
1	Granulomatous Mastitis 02/2008
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Carcinoma (Carcinomatosis) 01/2004

Drug/Important Bio-Agent (IBA)

7	Estrogen ReceptorsIBA 01/2021 - 01/2002
5	Tamoxifen FDA LinkGeneric 01/2011 - 07/2002
5	Aromatase InhibitorsIBA 03/2010 - 09/2006
4	Gefitinib (Iressa)FDA Link 01/2013 - 01/2002
3	Thromboplastin (Tissue Factor)IBA 08/2020 - 04/2017
3	Lapatinib (GW572016)FDA Link 01/2014 - 01/2013
3	Hormones (Hormone)IBA 02/2009 - 10/2002
2	ParaffinIBA 01/2021 - 04/2007
2	Blood Coagulation Factors (Coagulation Factor)IBA 08/2020 - 01/2020
2	Thrombin FDA Link 08/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 01/2009
2	Interleukin-8 (Interleukin 8)IBA 11/2013 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 10/2013 - 12/2003
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2013 - 04/2007
2	Notch ReceptorsIBA 01/2013 - 01/2010
2	tiboloneIBA 01/2012 - 02/2009
2	exemestane (Aromasin)FDA Link 03/2010 - 01/2008
2	Growth Factor ReceptorsIBA 01/2009 - 01/2006
2	Phosphotransferases (Kinase)IBA 01/2009 - 01/2002
2	Letrozole (Femara)FDA LinkGeneric 03/2008 - 09/2006
2	ErbB Receptors (EGF Receptor)IBA 04/2007 - 01/2002
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2005 - 01/2002
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	A-factor (Streptomyces)IBA 08/2020
1	RivaroxabanIBA 08/2020
1	AnticoagulantsIBA 08/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2015
1	CateninsIBA 02/2015
1	CytokinesIBA 11/2013
1	Pharmaceutical PreparationsIBA 10/2013
1	InterleukinsIBA 02/2013
1	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 02/2013
1	matrigelIBA 01/2013
1	Aromatase (CYP19)IBA 03/2010
1	Celecoxib (Celebrex)FDA Link 03/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2010
1	Notch4 ReceptorIBA 01/2010
1	Diphosphonates (Bisphosphonates)IBA 02/2009
1	Inhibitor of Apoptosis ProteinsIBA 01/2009
1	SurvivinIBA 01/2009
1	tyrosine receptor (receptor, tyrosine)IBA 01/2009
1	Zoledronic Acid (Zometa)FDA Link 03/2008
1	Immunoglobulin M (IgM)IBA 02/2008
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2008
1	Estrogens (Estrogen)FDA Link 01/2008
1	Epidermal Growth Factor (EGF)IBA 04/2007
1	TransferasesIBA 01/2006
1	tipifarnib (R115777)IBA 01/2006
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2004
1	Cyclin D1IBA 12/2003
1	Biological ProductsIBA 12/2003
1	Fulvestrant (Faslodex)FDA Link 07/2002
1	Tyrosine (L-Tyrosine)FDA Link 01/2002
1	Tyrosine Kinase InhibitorsIBA 01/2002
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2002

Therapy/Procedure

11	Therapeutics 05/2021 - 03/2005
6	Radiotherapy 10/2021 - 03/2005
3	Drug Therapy (Chemotherapy) 04/2013 - 09/2006
2	Segmental Mastectomy (Lumpectomy) 01/2014 - 03/2005
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2012 - 12/2003
2	Chemoprevention 01/2005 - 10/2002
1	Operative Surgical Procedures 01/2016
1	Mastectomy (Mammectomy) 01/2016
1	VAB II protocol 01/2016
1	Lymph Node Excision (Lymph Node Dissection) 11/2014
1	Ovariectomy (Oophorectomy) 01/2008